Generics - Asia-Pacific, Markets & Marketing

Filter

Popular Filters

1 to 25 of 54 results

Despite focus on generics, South Korean pharma market to reach $24.3 billion by 2020

Despite focus on generics, South Korean pharma market to reach $24.3 billion by 2020

10-04-2014

As a result of a high level of access to health care insurance and reimbursement, coupled with increasing…

Asia-PacificGenericsMarkets & MarketingPolitics

Generic pains for AstraZeneca exacerbated by Indian drugmakers

Generic pains for AstraZeneca exacerbated by Indian drugmakers

06-04-2014

Indian generic companies are taking aim at mega blockbusters, and AstraZeneca, the $25.7 billion pharmaceutical…

Asia-PacificAstraZenecaDr Reddy's LaboratoriesFinancialGastro-intestinalsGenericsIndiaMarkets & MarketingNexiumPharmaceuticalPulmicortRanbaxy LaboratoriesRespiratory and PulmonarySymbicortUSAVimovo

Actavis opens new Asia Pacific regional headquarters in Singapore

03-04-2014

Ireland-headquartered generics major Actavis has officially opened its new regional office in Singapore…

ActavisAsia-PacificGenericsManagementMarkets & Marketing

Philippine government increasing financial support for health care spending

28-03-2014

The size of the Philippine pharmaceutical market, now worth around $3.2 billion, is expected to expand…

Asia-PacificFinancialGenericsMarkets & MarketingPharmaceutical

Mylan pushes further into India, introducing critical care segment

Mylan pushes further into India, introducing critical care segment

12-03-2014

US generics major Mylan says its Indian subsidiary has launched a Critical Care segment in India. The…

AmbisomeAntibiotics and Infectious diseasesAsia-PacificGenericsIndiaMarkets & MarketingMylan Laboratories

Tacrolimus Sandoz gets sole subsidy supply status in New Zealand

Tacrolimus Sandoz gets sole subsidy supply status in New Zealand

07-03-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC has decided to award immunosuppressant drug…

Asia-PacificGenericsImmunologicalsMarkets & MarketingNew ZealandNovartisPricingSandozTacrolimus Sandoz

Mylan debuts Hertraz, first Herceptin biosimilar, in India

Mylan debuts Hertraz, first Herceptin biosimilar, in India

03-02-2014

US generics major Mylan has launched the world's first trastuzumab biosimilar in India. The product,…

Asia-PacificBioconBiosimilarsGenericsHerceptinHertrazIndiaMarkets & MarketingMylan LaboratoriesOncologyRoche

Rise or demise of Japan’s generics by P Reed Maurer

Rise or demise of Japan’s generics by P Reed Maurer

16-10-2013

Generics in Japan are a work in progress. Presently they account for about 28% of pharmaceutical volume,…

Asia-PacificGenericsMarkets & MarketingPricing

Dramatic increase in use of generic drugs in Japan confirmed

Dramatic increase in use of generic drugs in Japan confirmed

15-10-2013

A subcommittee of Japan’s Central Social Insurance Medical Council looked at the effect of the April…

Asia-PacificGenericsMarkets & MarketingRegulation

Australian generics group releases new edition of Code of Practice for public consultation

Australian generics group releases new edition of Code of Practice for public consultation

26-09-2013

Australia’s Generic Medicines Industry Association this morning released the draft third edition of…

Asia-PacificGenericsMarkets & MarketingRegulation

Rising focus on R&D in India whose pharma exports have reached $14.5 billion

Rising focus on R&D in India whose pharma exports have reached $14.5 billion

24-09-2013

The domestic pharmaceutical industry in India has been growing at a CAGR of over 14.5% for the past four…

Asia-PacificGenericsMarkets & MarketingRegulation

Australia needs policies that increase generic medicine use

24-09-2013

Australia’s Generic Medicines Industry Association strongly refutes claims by the Consumer Health Forum…

Asia-PacificGenericsMarkets & MarketingPolitics

Generics market in Southeast Asia set for growth

15-09-2013

With its fast-growing, young population and uninsured majority in Southeast Asia, countries in the region…

Asia-PacificGenericsMarkets & MarketingPricingRegulation

Fresenius Kabi sets up JV for IV generics in Indonesia

20-08-2013

Germany-based Fresenius Kabi, part of the Fresenius Group (FRE: Xetra) has formed a joint venture with…

Asia-PacificFreseniusFresenius KabiGenericsMarkets & MarketingMergers & AcquisitionsSoho Global Health

Indian pharma threatened by trend of shifting R&D operations overseas: survey

04-07-2013

Red tape is putting India's multi-billion dollar worth pharmaceutical industry at risk, with most of…

Asia-PacificGenericsMarkets & MarketingPharmaceuticalRegulationResearch

Government health care reforms foster development China's Pharma market, says F&S

28-05-2013

Rising incomes, improving health care infrastructure and enhanced insurance systems have propelled the…

Asia-PacificGenericsHealthcareMarkets & MarketingPatentsPharmaceuticalPolitics

Mylan delivers "one pill once a day" ARV in South Africa; Cipla Debuts first Enbrel biosimilar

17-04-2013

USA-based generic drugmaker Mylan (Nasdaq: MYL) says that it has delivered, through its South African-based…

AmgenAnti-Arthritics/RheumaticsAnti-viralsAsia-PacificBiotechnologyCiplaEnbrelEtaceptGenericsMarkets & MarketingMylan LaboratoriesPfizerRest of the World

Indian Pharma growth outpaces rivals, but must embrace innovation

12-03-2013

Ranking among the top five globally by production volume, the Indian pharmaceutical market at present…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProductionResearch

Thailand flouts pharmaceutical patent protection; report

08-03-2013

Lax enforcement of patent regulations in Thailand is alienating American intellectual property laws,…

Asia-PacificGenericsMarkets & MarketingPatentsPharmaceutical

PHARMAC holding back New Zealand health care industry growth, says GlobalData

26-02-2013

Despite disproportionate elderly population growth and an unsaturated market acting as key drivers, growth…

Asia-PacificGenericsMarkets & MarketingPharmaceuticalPricing

Indian pharmaceuticals market led by Ranbaxy in terms of revenue

31-01-2013

The Indian pharmaceutical market is the world's third-largest in terms of volume and stands 14th in terms…

Asia-PacificBioconBiotechnologyGenericsMarkets & MarketingPanacea BiotecPharmaceuticalRanbaxy LaboratoriesSerum Institute of India

Daiichi Sankyo and Ranbaxy combine business operations in Thailand

16-01-2013

Japanese pharma major Daiichi Sankyo (TYO: 4568) and its 64%-owned affiliate Ranbaxy Laboratories (AB:…

Asia-PacificDaiichi SankyoGenericsManagementMarkets & MarketingPharmaceuticalRanbaxy Laboratories

1 to 25 of 54 results

Back to top